NLRP3 and atherosclerosis: In our experiments that modulated Olfr2 expression both in vitro and in vivo, we observed analogous outcomes confirming that the Olfr2 signaling pathway indeed activated the NLRP3 inflammasome, exacerbating atherosclerosis development and progression.